RM

Romala Maheswari

Active Director Director DIN 10151062
DIN 10151062 First appointment Mar 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Romala Maheswari

Data last updated:

Romala Maheswari is a Director at Accore Pharmaceuticals Private Limited (since 2023). The company operates in Trading. Accore Pharmaceuticals Private Limited reported revenue of ₹14 Lakh (FY 2022).

DIN 10151062
Primary Designation Director
Industry Trading
First Appointment 29 Mar 2023
Oldest Company Age 7 yrs
Largest company Accore Pharmaceuticals Private Limited · ₹14 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20232019₹14 Lakh (FY 2022)Active

Board colleagues of Romala Maheswari

Directorship timeline

Open interactive timeline →
Accore Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Romala Maheswari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Romala Maheswari

Romala Maheswari currently holds 1 directorship: Accore Pharmaceuticals Private Limited (Director, since 29 Mar 2023, revenue ₹14 Lakh (FY 2022)).

Romala Maheswari was first appointed on 29 Mar 2023 as Director at Accore Pharmaceuticals Private Limited.

The current boards of Romala Maheswari's companies include Sree Raghavendra Kumar Tamada (Accore Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available